We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Janani Rangaswami

Janani Rangaswami MD, FACP, FCRS, FAHA

Associate Chair (Research), Department of Internal Medicine, Einstein Medical Center; Clinical Associate Professor, Thomas Jefferson University, Philadelphia, Pennsylvania

Janani Rangaswami is a nephrologist who maintains an active clinical and research practice in nephrology and cardio-renal medicine at Einstein Medical Center, Philadelphia.  She serves as the Associate Chair (Research) for the Department of Internal Medicine. She is a Clinical Associate Professor at Thomas Jefferson University, and has won several awards from residents and fellows for clinical teaching and mentorship. She is the Vice Chair of the Kidney Council of the American Heart Association (AHA). She led the first AHA Scientific Statement on Cardio-Renal Syndrome (2019) as well as the AHA Scientific Statement on Cardiorenal Benefits of the Novel Antidiabetic Agents in CKD (2020). She is the lead editor of the Textbook of Cardio-nephrology (Springer 2018) and the Textbook of Kidney Disease in the Cardiac Catheterization Laboratory (Springer 2020).  Janani Rangaswami completed medical school from the MGR Medical University, Chennai, India where she graduated as the valedictorian of her class with several awards of distinction. She then went on to complete her residency and chief residency in Internal Medicine at Albert Einstein Medical Center, Philadelphia and a fellowship in Nephrology at Weill Cornell Medical Center, NY. She has spoken and presented work at several national and international specialty meetings in the cardio-renal space.   

Disclosures

Dr. Rangaswami has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Finerenone in Chronic Kidney Disease in Type 2 Diabetes